Reaction
Croup Infectious reporting signals
As of the last recalculation, Croup Infectious appears in 764 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is PALIVIZUMAB (PRR 86.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Palivizumab | 46 | 86.7 | 87.0 |
| Ciclesonide | 14 | 28.5 | 28.5 |
| Human Immunoglobulin G | 21 | 28.5 | 28.5 |
| Fexofenadine Hcl | 9 | 26.8 | 26.9 |
| Lumacaftor And Ivacaftor | 7 | 22.4 | 22.5 |
| Adrenalinum | 30 | 20.5 | 20.5 |
| Indapamide | 13 | 20.1 | 20.1 |
| Vigabatrin | 10 | 18.9 | 18.9 |
| Dornase Alfa | 11 | 15.5 | 15.5 |
| Fexofenadine Hydrochloride | 11 | 14.0 | 14.0 |
| Ivacaftor | 4 | 13.8 | 13.8 |
| Emicizumab | 4 | 8.9 | 8.9 |
| Benralizumab | 5 | 6.8 | 6.8 |
| Dupilumab | 57 | 3.4 | 3.4 |